Autogenous Vaccines, Built Around Your Isolates

A Veterinarian‑guided, USDA‑licensed Approach to Custom Disease Management in the United States

Kemin manufactures autogenous vaccines using pathogens isolated from your herd, flock, or production system rather than generic reference strains. Under a valid Veterinarian-Client-Patient Relationship (VCPR), we work with licensed U.S. veterinarians to develop custom biologics for disease challenges when commercial options are not sufficient

What Is an Autogenous Vaccine?

Autogenous vaccines are custom veterinary biologics manufactured from isolates obtained from a specific herd, flock, or defined geographic region. In the United States, they are produced in USDA‑licensed facilities and prescribed by licensed veterinarians under a valid VCPR.*

When Do US Veterinarians Use Autogenous Vaccines?

• Commercial vaccines do not adequately match circulating field strains
• Recurrent disease despite established vaccination programs
• Emerging, shifting, or system‑specific pathogen profiles
• Multi‑strain or complex disease challenges

Why Partner with Kemin?

Kemin’s autogenous vaccines are built around the isolates identified in your operation and the disease challenges you are managing. Projects can be tailored in antigen selection and formulation to reflect field conditions across U.S. production systems.

All autogenous projects with Kemin are initiated and guided by licensed U.S. veterinarians working within a valid VCPR. We provide clear communication from isolate receipt through vaccine release, and all vaccines are produced in a USDA-licensed facility with required safety and sterility testing.

*Autogenous vaccines do not carry USDA‑approved efficacy claims and are used at the discretion of the prescribing veterinarian.

Is an Autogenous Vaccine the Right Option for Your Operation?

Fill out the form below to connect with one of our experts.